- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04102072
The Consistency of Cardiac Output Measurements by Different Methods in VA-ECMO Patients
September 24, 2019 updated by: Shanghai Zhongshan Hospital
Objective:
- To evaluate the consistency of cardiac output measured by different hemodynamic monitoring methods in patients with VA-ECMO
- To evaluate whether different hemodynamic monitoring methods can accurately detect the trend of cardiac output changes
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
Venoarterial extracorporeal membrane oxygenation (VA-ECMO) has been used for profound cardiogenic shock to bridge to decision,ventricular assist devices,or transplant.Close monitoring of cardiac output, especially in patients before and after intervention (such as volume expansion, diuresis, vasoconstriction, vasodilation therapy), can help to adjust the treatment strategy.
Hemodynamic monitoring in ECMO patients requires familiarity with the underlying pathophysiology and circulatory mechanics of extracorporeal flow.Limited to the actual clinical situation of patients, one or two hemodynamic monitoring methods may be accepted.
Is there consistency between different hemodynamic monitoring results?
And whether hemodynamic monitoring can accurately detect the changes of these parameters before and after intervention is an important issue in clinical practice.
This study will provide important reference for VA-ECMO patients how to choose appropriate hemodynamic monitoring tools and how to interpret the results of hemodynamic monitoring.
Study Type
Interventional
Enrollment (Anticipated)
20
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Jun-yi Hou, Doctor
- Phone Number: 86-021-64041990
- Email: hou.junyi@zs-hospital.sh.cn
Study Locations
-
-
-
Shanghai, China, 200032
- Recruiting
- Zhongshan Hospital, Fudan University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- cardiac surgery
- treatment with VA-ECMO
- mechanical ventilation
- hemodynamic monitoring according to patient's condition (PAC, Flotrac, echocardiography)
Exclusion Criteria:
- age < 18
- cardiac arrhythmia
- moderate to severe aortic, mitral and tricuspid regurgitation
- active hemorrhage
- IABP
- spontaneous triggering of the ventilator
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Trendelenburg Maneuver
The Trendelenburg position is a common treatment in medicine.It is used either as a diagnostic tool to assess fluid loading response or as a therapeutic maneuver pending fluid resuscitation.With the advantage of autotransfusion readily available,the Trendelenburg position is used for expected instantaneous effect on cardiovascular performance.
|
In the Trendelenburg position, the body is laid supine with the feet higher than the head by 15-30 degrees.
The venous return increases in the trendelenburg position which in turn increases the stroke volume.
|
Experimental: dobutamine stress test
Dobutamine is a selective beta 1 receptor agonist.
It [<10 ug/(kg.min)]
can effectively increase myocardial contractility.
|
Dobutamine was infused intravenously at the initial dose of 2.5 ug/kg/min.
Echocardiography was performed after 5-10 minutes of continuous infusion, and hemodynamic data were recorded.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Baseline Cardiac Output measurement
Time Frame: within1 minute at baseline position
|
Cardiac Output measured at baseline position( in a supine position with the head elevated to 15° for baseline measurements )
|
within1 minute at baseline position
|
Cardiac Output measurement afterTrendelenburg Maneuver
Time Frame: 1 minute after starting Trendelenburg Maneuver
|
Cardiac Output measured after Trendelenburg Maneuver
|
1 minute after starting Trendelenburg Maneuver
|
Cardiac Output measurement after Dobutamine stress test
Time Frame: 5 minutes after dobutamine stress test
|
Cardiac Output measured after dobutamine stress test
|
5 minutes after dobutamine stress test
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 23, 2019
Primary Completion (Anticipated)
August 1, 2024
Study Completion (Anticipated)
August 1, 2024
Study Registration Dates
First Submitted
September 10, 2019
First Submitted That Met QC Criteria
September 22, 2019
First Posted (Actual)
September 25, 2019
Study Record Updates
Last Update Posted (Actual)
September 26, 2019
Last Update Submitted That Met QC Criteria
September 24, 2019
Last Verified
September 1, 2019
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Physiological Effects of Drugs
- Adrenergic Agents
- Neurotransmitter Agents
- Molecular Mechanisms of Pharmacological Action
- Autonomic Agents
- Peripheral Nervous System Agents
- Protective Agents
- Adrenergic Agonists
- Cardiotonic Agents
- Adrenergic beta-Agonists
- Sympathomimetics
- Adrenergic beta-1 Receptor Agonists
- Dobutamine
Other Study ID Numbers
- COMMENT
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Extracorporeal Membrane Oxygenation
-
UMC UtrechtErasmus Medical Center; Catharina Ziekenhuis Eindhoven; St. Antonius Hospital; Leiden... and other collaboratorsRecruitingExtracorporeal Membrane Oxygenation | Extracorporeal Membrane Oxygenation ComplicationNetherlands
-
Transonic Systems Inc.National Heart, Lung, and Blood Institute (NHLBI)TerminatedCardiac Output | Venoarterial Extracorporeal Membrane Oxygenation | Venovenous Extracorporeal Membrane Oxygenation | Recirculation | Oxygenator Blood VolumeUnited States
-
JinyanXingNot yet recruitingExtracorporeal Membrane OxygenationChina
-
Daping Hospital and the Research Institute of Surgery...Beijing 302 Hospital; The First Hospital of Jilin University; Hunan Provincial... and other collaboratorsCompleted
-
National Taiwan University HospitalCompleted
-
Xiaobo Yang, MDRecruitingExtracorporeal Membrane OxygenationChina
-
Second Affiliated Hospital of Zhengzhou UniversityRecruitingExtracorporeal Membrane OxygenationChina
-
Policlinico HospitalThe Mediterranean Institute for Transplantation and Advanced Specialized...Completed
-
Rennes University HospitalCompletedExtraCorporeal Membrane OxygenationFrance
-
Spectrum Health HospitalsVan Andel Research InstituteCompletedExtracorporeal Membrane OxygenationUnited States
Clinical Trials on Trendelenburg Maneuver
-
Shanghai Zhongshan HospitalUnknownExtracorporeal Membrane OxygenationChina
-
Bicetre HospitalCompletedSeptic Shock | Acute Respiratory Distress Syndrome | Hemodynamic InstabilityFrance
-
Hospices Civils de LyonRecruitingAcute Respiratory Distress SyndromeFrance
-
Advocate Health CareTerminatedBenign Female Reproductive System NeoplasmUnited States
-
Midwestern UniversityNorthwestern UniversityWithdrawnVertigo | Vestibular DiseaseUnited States
-
Medical University of GdanskRecruitingShock | Hypovolemia | Hemodynamic InstabilityPoland
-
Chonbuk National UniversitySeoul National University Bundang HospitalCompletedHC-BPPVKorea, Republic of
-
Chonbuk National UniversityUnknownBenign Paroxysmal Positional Vertigo (BPPV)Korea, Republic of
-
Hospices Civils de LyonCompletedARDS PATIENTS WITH HEMODYNAMIC INSTABILITYFrance
-
Rambam Health Care CampusRecruitingBreech Presentation of Fetus With Successful VersionIsrael